Data based on ATAC-seq, Hi-C, Capture Hi-C, and nuclear RNA-seq analysis in stimulated CD4+ T cells suggest that MYC and FOXO1 genes may also be causal factors in RA and may therefore be candidates for gene therapy [78]. The gene discussed is CD4; the disease is rheumatoid arthritis.